Rockefeller Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.09M Sell
80,420
-167,059
-68% -$6.42M 0.01% 946
2025
Q1
$9.59M Sell
247,479
-88,352
-26% -$3.42M 0.02% 577
2024
Q4
$11.4M Sell
335,831
-23,398
-7% -$791K 0.03% 520
2024
Q3
$14.7M Sell
359,229
-2,006
-0.6% -$82K 0.04% 427
2024
Q2
$13.9M Buy
361,235
+10,182
+3% +$392K 0.04% 414
2024
Q1
$15M Sell
351,053
-9,719
-3% -$417K 0.04% 401
2023
Q4
$13.4M Sell
360,772
-150,471
-29% -$5.58M 0.04% 382
2023
Q3
$18.5M Buy
511,243
+80,919
+19% +$2.93M 0.07% 277
2023
Q2
$15.3M Buy
430,324
+38,378
+10% +$1.37M 0.06% 339
2023
Q1
$13.9M Sell
391,946
-57,026
-13% -$2.03M 0.06% 349
2022
Q4
$15.8M Buy
448,972
+28,093
+7% +$987K 0.08% 274
2022
Q3
$12.4M Buy
420,879
+128,179
+44% +$3.77M 0.06% 303
2022
Q2
$15.9M Buy
292,700
+94,497
+48% +$5.14M 0.08% 244
2022
Q1
$10.8M Buy
198,203
+9,901
+5% +$539K 0.05% 343
2021
Q4
$10.4M Buy
188,302
+19,256
+11% +$1.06M 0.05% 343
2021
Q3
$8.07M Buy
169,046
+17,742
+12% +$847K 0.04% 354
2021
Q2
$7.53M Buy
151,304
+43,570
+40% +$2.17M 0.04% 349
2021
Q1
$4.81M Buy
107,734
+8,864
+9% +$395K 0.03% 379
2020
Q4
$4.55M Sell
98,870
-2,149,552
-96% -$98.8M 0.03% 344
2020
Q3
$106M Sell
2,248,422
-8,881
-0.4% -$418K 0.99% 16
2020
Q2
$115M Sell
2,257,303
-798,200
-26% -$40.7M 1.2% 13
2020
Q1
$145M Buy
3,055,503
+3,035,456
+15,142% +$144M 1.9% 10
2019
Q4
$1.18M Buy
20,047
+746
+4% +$43.8K 0.01% 422
2019
Q3
$1.03M Buy
19,301
+1,229
+7% +$65.5K 0.01% 385
2019
Q2
$904K Buy
18,072
+10,922
+153% +$546K 0.01% 355
2019
Q1
$373K Buy
+7,150
New +$373K 0.01% 517